These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 14513927)
1. Current therapy and future treatment strategies for depression (Paris, January 2003). Moret C J Psychopharmacol; 2003 Sep; 17(3):337-41. PubMed ID: 14513927 [No Abstract] [Full Text] [Related]
2. Restoring value to stalled Phase II compounds: the case for developing a novel compound for depression using pharmacogenetics. Reed C; Kalnik M; Rakin K; Athanasiou M; Judson R Pharmacogenomics; 2005 Mar; 6(2):95-100. PubMed ID: 15882128 [No Abstract] [Full Text] [Related]
3. The future of antidepressant pharmacogenetics is arriving. Introduction. Holsboer F Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jul; 29(6):996-8. PubMed ID: 16002199 [No Abstract] [Full Text] [Related]
4. Integration of machine learning and pharmacogenomic biomarkers for predicting response to antidepressant treatment: can computational intelligence be used to augment clinical assessments? Athreya AP; Iyer R; Wang L; Weinshilboum RM; Bobo WV Pharmacogenomics; 2019 Sep; 20(14):983-988. PubMed ID: 31559920 [No Abstract] [Full Text] [Related]
5. Dialogues in clinical neuroscience. Remission in depression. Naber D Dialogues Clin Neurosci; 2008; 10(4):369-70. PubMed ID: 19170393 [No Abstract] [Full Text] [Related]
6. Pharmacogenomic strategy for individualizing antidepressant therapy. Lin KM; Perlis RH; Wan YJ Dialogues Clin Neurosci; 2008; 10(4):401-8. PubMed ID: 19170397 [TBL] [Abstract][Full Text] [Related]
7. [International colloquium. Depression resistant to antidepressive treatment. Paris (France), 17 January 1986]. Encephale; 1986 Oct; 12 Spec No():187-262. PubMed ID: 3816682 [No Abstract] [Full Text] [Related]
8. The pharmacogenetics of depression: enter the GWAS. Malhotra AK Am J Psychiatry; 2010 May; 167(5):493-5. PubMed ID: 20439394 [No Abstract] [Full Text] [Related]
9. [Current state and potential of pharmacogenetic studies in the treatment of depression]. Ivanets NN; Tikhonova YG; Kinkulkina MA; Avdeeva TI Zh Nevrol Psikhiatr Im S S Korsakova; 2015; 115(3):113-121. PubMed ID: 26171487 [TBL] [Abstract][Full Text] [Related]
10. Pharmacogenetic studies of depression. Henn FA Biol Psychiatry; 2008 Jun; 63(12):1101-2. PubMed ID: 18514642 [No Abstract] [Full Text] [Related]
11. [Pharmacogenetics of depression in elderly patients]. Monnin J; Haffen E; Sechter D; Vandel P Psychol Neuropsychiatr Vieil; 2009 Mar; 7(1):43-55. PubMed ID: 19251571 [TBL] [Abstract][Full Text] [Related]
15. Pharmacogenetics of antidepressant drugs: current clinical practice and future directions. Narasimhan S; Lohoff FW Pharmacogenomics; 2012 Mar; 13(4):441-64. PubMed ID: 22380000 [TBL] [Abstract][Full Text] [Related]
16. [Recovery from depression. 8th international thematic meeting. Paris, 27 November 1992. Proceedings]. Encephale; 1993 Aug; 19 Spec No 3():439-500. PubMed ID: 8299541 [No Abstract] [Full Text] [Related]
17. [Individualized treatment with tricyclic antidepressives. The pharmacogenetics of depression]. Hiemke C Pharm Unserer Zeit; 2008; 37(3):234-40. PubMed ID: 18446907 [No Abstract] [Full Text] [Related]
18. Drug therapy strategies for treatment-resistant depression. Wager SG; Klein DF Psychopharmacol Bull; 1988; 24(1):69-74. PubMed ID: 3290951 [No Abstract] [Full Text] [Related]
19. Pharmacogenomics and Global Precision Medicine in the Context of Adverse Drug Reactions: Top 10 Opportunities and Challenges for the Next Decade. Alessandrini M; Chaudhry M; Dodgen TM; Pepper MS OMICS; 2016 Oct; 20(10):593-603. PubMed ID: 27643672 [TBL] [Abstract][Full Text] [Related]